MARC Record from Library of Congress

LEADER: 05186cam a22003854a 4500
001 2011015547
003 DLC
005 20120426082040.0
008 110412s2011 enk bf 001 0 eng
010 $a 2011015547
016 7 $a101558374$2DNLM
016 7 $a015799078$2Uk
020 $a9780521124652 (pbk.)
020 $a0521124654 (pbk.)
035 $a(OCoLC)ocn714029810
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dYDXCP$dUKMGB$dOCLCO$dDLC
042 $apcc
050 00 $aRC456$b.T97 2011
060 10 $aWM 34
082 00 $a616.89$223
100 1 $aTyrer, Peter J.
245 10 $aEffective treatments in psychiatry /$cPeter Tyrer, Kenneth R. Silk.
260 $aCambridge ;$aNew York :$bCambridge University Press,$c2011.
300 $axi, 563 p. ;$c19 cm.
490 1 $aCambridge medicine
504 $aIncludes bibliographical references and index.
505 8 $aMachine generated contents note: Preface; Part I. Organic Disorders: 1. Delirium; 2. Management of behavioural and psychological symptoms of dementia and acquired brain injury; 3. Pharmacological and non-pharmacological treatments for deficits in dementia; 4. Pharmacological treatment of psychosis and depression in neurological disease in older adults; Part II. Alcohol: 5. Psychological treatments of alcohol use disorders; 6. Pharmacotherapy of alcohol misuse, dependence and withdrawal; 7. Educational interventions for alcohol use disorders; 8. Complex interventions for alcohol use disorders; 9. Complementary and alternative medicine for alcohol misuse; Part III. Drug Misuse: 10. Empirically-validated psychological therapies for drug dependence; 11. Treatment of stimulant dependence; 12. Treatment of opioid dependence; 13. Treatment of sedative-hypnotic dependence; 14. Treatment of cannabis dependence; 15. Treatment of nicotine dependence; 16. Treatment of co-occurring psychiatric and substance use disorders; Part IV. Schizophrenia: 17. Pharmacological treatments for schizophrenia; 18. Psychological treatments for schizophrenia; Part V. Mood Disorders: 19. Psychopharmacology of mood disorders; 20. Efficacy of brain stimulation and neurosurgical procedures for treatment of mood disorders; 21. Psychotherapy for depression: current empirical status and future directions;
505 8 $a22. Alternative treatments for mood disorders; Part VI. Anxiety and Neurotic Disorders: 23. Treatment of generalized anxiety and somatoform disorders; 24. Panic disorder; 25. Specific phobias and agoraphobia; 26. Social phobia; 27. Obsessive-compulsive disorder; 28. Post-traumatic stress and adjustment disorders; Part VII. Eating Disorders: 29. Psychopharmacology of eating disorders; 30. Other somatic physical treatments and complex interventions for eating disorders; 31. Psychological treatments for eating disorders; 32. Educational interventions for eating disorders; 33. Alternative treatments for eating disorders; 34. Complex treatments for eating disorders; Part VIII. Personality Disorders: 35. Personality disorder; 36. Other treatments for persistent disturbances of behaviour; Part IX. Sexual and Gender Identity Disorders: 37. Effectiveness of treatments of sexual disorders; 38. Disorders of gender identity; Part X. Child Psychiatry: 39. Psychological treatments for children and adolescents; 40. Drugs and other physical treatments; 41. Educational interventions and alternative treatments; 42. Attachment insecurity and attachment disorder; 43. Feeding and sleeping disorders in infancy and early childhood; 44. Evaluating interventions for children with autism and intellectual disabilities; 45. ADHD and hyperkinetic disorder; 46. Oppositional defiant disorder and conduct disorder; 47. Treatment of depressive disorders in children and adolescents; 48. Treatment of psychoses in children and adolescents; 49. Anxiety disorders; 50. Treatment of eating disorders in children and adolescents; List of drug treatments and licences indications; Appendix I; Appendix II. Key to effectiveness tables.
520 $a"Delirium needs treatment for both its causes and manifestations, as, if ignored, it is associated with excessive periods of hospitalisation or early mortality. The common causes include infection, drug intoxication, renal or hepatic insufficiency, vascular disease affecting the brain, and (often forgotten) electrolyte disturbance. The main interventions are environmental and pharmacological and the symptoms on which they are focused are agitation, over-activity, restlessness and other behavioural disturbance, and psychotic symptoms such as hallucinations, delusions and paranoid reconstruction of the world. As might be expected, randomised controlled trials are very difficult to carry out in this population as its manifestations are acute and cannot be ignored, and most of the evidence of efficacy of interventions is based on less convincing models"--Provided by publisher.
650 0 $aPsychiatry$vHandbooks, manuals, etc.
650 0 $aMental illness$xTreatment$vHandbooks, manuals, etc.
650 12 $aMental Disorders$xtherapy$vHandbooks.
650 22 $aPsychiatry$xmethods$vHandbooks.
700 1 $aSilk, Kenneth R.,$d1944-
830 0 $aCambridge medicine.